Sensei Biotherapeutics is laying off 46% of its workforce as the cancer-focused biotech looks to preserve cash to take its immune checkpoint inhibitor through phase 2. The asset in question ...

This strategy, shared by many if not most large companies, contrasts sharply with what I call "sensei leadership," which centers on mentoring and personal growth. While Microsoft’s AI agents may ...

BOSTON, March 27, 2025 (GLOBE NEWSWIRE) -- Sensei Biotherapeutics, Inc. (Nasdaq: SNSE), a clinical-stage biotechnology company focused on the discovery and development of next-generation ...

In Europe, Portuguese startup Sensei has been capitalizing on this momentum to grow its contactless store platform, and it has now raised €15 million (about $16.2 million) in a Series A funding ...

OKYO Pharma's announcement was made in a formal SEC filing on Wednesday, February 12, 2025, underscoring the company's commitment to transparency and regulatory compliance. The information ...

Sensei Biotherapeutics Inc. SNSE late Thursday released initial results from the dose expansion portion of its Phase 1/2 trial evaluating solnerstotug (formerly SNS-101) for cancer. Six PD-(L ...

Fewer people buzzed over his reinvention of the neighboring, 34-acre Koele Lodge. But the first Sensei wellness resort, which opened in 2018, would technically be far more visionary. Fast-forward ...